Loading chat...

KS SB236

Bill

Status

Failed

4/30/2024

Primary Sponsor

Public Health and Welfare

Click for details

Origin

Senate

2023-2024 Regular Session

AI Summary

Legislative Description

Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Last Action

Senate Died in Committee

4/30/2024

Committee Referrals

Financial Institutions and Insurance2/13/2023

Full Bill Text

No bill text available